Your session is about to expire
← Back to Search
Healthy males for Healthy Subjects
Study Summary
This trial will examine whether the epilepsy drug perampanel has any effect on commonly used neurophysiology tests. Twelve healthy male subjects will receive 6mg of perampanel, have their blood drawn, and then have their neurophysiology tested. There is no placebo group or randomization.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 12 Patients • NCT03653741Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the study accept participants aged 70 or above?
"This clinical trial is accepting participants aged 18 and up to 50 years old."
Does the intake of Healthy males present any risks to individuals?
"There is extensive clinical data confirming the safety of healthy males, thus earning this treatment a score of 3."
What research has been undertaken regarding the health of male volunteers?
"Currently, 11 clinical trials are researching Healthy males with 0 of those in the Phase 3 stage. The majority of these experiments take place within New york City but there are 93 other sites around America conducting research on this category."
Is this medical trial accepting new participants at present?
"Unfortunately, this trial is not currently accepting participants. The study was originally published on October 1st 2018 and last modified December 20th 2021. Fortunately, 841 trials with healthy subjects (HS) are admitting patients at the moment as well as 11 studies that only require male volunteers."
May I be included in this medical experiment?
"The inclusion criteria for this medical trial stipulates that participants must be between 18 to 50 years of age and possess healthy subject status. The research team is seeking a total of 12 potential patients."
Does this trial present a paradigm shift in the field?
"As of now, 11 active trials for Healthy males are transpiring internationally in 9 countries and 51 cities. In 2017, Eisai Inc. sponsored the inaugural trial related to this topic which required 60 participants and culminated with an unspecified step in drug approval process. Subsequently, 52 studies have since been successfully concluded."
How many participants are being included in the research?
"At this moment in time, recruitment for the study has been concluded. It began on October 1st 2018 and ended December 20th 2021. However, there are 841 studies actively seeking healthy subjects (hs) as well as 11 trials recruiting Healthy males right now."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger